Pediatrics
Feature
Boosting the presence of darker skin in rheumatology education
Doctors are beginning to address educational gaps in rheumatologists’ exposure to rheumatic and musculoskeletal diseases in people with darker...
Conference Coverage
Early pediatric rheumatology residency exposure key to solving workforce shortages
A new study suggests that increasing medical students’ and residents’ exposure to pediatric rheumatology earlier in training could help improve...
Conference Coverage
Risk of hypogammaglobulinemia, infections with rituximab increased in pediatric patients
Although immunosuppressing drugs often come with an elevated risk of depleted antibodies, the risk from rituximab is particularly higher in...
From the Journals
Data about COVID-19-related skin manifestations in children continue to emerge
Of 50 hospitalized children infected with COVID-19, 18 (36%) fulfilled criteria for Multisystem Inflammatory Syndrome in Children.
From the Journals
Secukinumab brings high PASI 75 results in 6- to 17-year-olds with psoriasis
The week-24 PASI 75 rate was 95% in a phase 2 study.
From the Journals
Researchers stress importance of second COVID-19 vaccine dose for infliximab users
Significantly lower antibody concentrations seen after a first dose of the Pfizer or AstraZeneca vaccine in users of infliximab vs. vedolizumab...
From the Journals
COVID-19 vaccination in RMD patients: Safety data “reassuring”
Two studies show mainly mild reactions and favorable antibody responses in patients with rheumatic and musculoskeletal diseases after vaccination...
Conference Coverage
Success in achondroplasia spurs testing vosoritide in more growth disorders
The quality of growth achieved with vosoritide in achondroplasia is leading to studies in more growth disorders.
From the Journals
Is pediatric subspecialty training financially worth it?
"Most pediatric subspecialists don't experience a relative increase in compensation after training compared to a general pediatrician."
Feature
MIS-C follow-up proves challenging across pediatric hospitals
First came the challenge of figuring out the best treatment regimen for patients with MIS-C. Then physicians had to think about follow-up.
From the Journals
ACR, AAD, AAO, RDS issue joint statement on safe use of hydroxychloroquine
Four medical societies issued a joint statement on the low risk of retinopathy and risk factor management.